186 related articles for article (PubMed ID: 31201431)
1. The use of PET/MRI for imaging rectal cancer.
Hope TA; Kassam Z; Loening A; McNamara MM; Paspulati R
Abdom Radiol (NY); 2019 Nov; 44(11):3559-3568. PubMed ID: 31201431
[TBL] [Abstract][Full Text] [Related]
2. Initial M Staging of Rectal Cancer: FDG PET/MRI with a Hepatocyte-specific Contrast Agent versus Contrast-enhanced CT.
Yoon JH; Lee JM; Chang W; Kang HJ; Bandos A; Lim HJ; Kang SY; Kang KW; Ryoo SB; Jeong SY; Park KJ
Radiology; 2020 Feb; 294(2):310-319. PubMed ID: 31793850
[TBL] [Abstract][Full Text] [Related]
3. PET/MRI and PET/CT hybrid imaging of rectal cancer - description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study.
Rutegård MK; Båtsman M; Axelsson J; Brynolfsson P; Brännström F; Rutegård J; Ljuslinder I; Blomqvist L; Palmqvist R; Rutegård M; Riklund K
Cancer Imaging; 2019 Jul; 19(1):52. PubMed ID: 31337428
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of
Hotta M; Minamimoto R; Yano H; Gohda Y; Shuno Y
Cancer Imaging; 2018 Jan; 18(1):4. PubMed ID: 29378659
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of [18F]FDG PET/MRI with Early-Delayed and Extended PET as One-Stop Imaging for Staging and Predicting Metastasis in Rectal Cancer.
Seto S; Tsujikawa T; Sawai K; Kurebayashi H; Morikawa M; Okazawa H; Goi T
Oncology; 2022; 100(4):212-220. PubMed ID: 35086111
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of FDG-PET/MRI versus pelvic MRI and thoracic and abdominal CT for detecting synchronous distant metastases in rectal cancer patients.
Queiroz MA; Ortega CD; Ferreira FR; Nahas SC; Cerri GG; Buchpiguel CA
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):186-195. PubMed ID: 32561971
[TBL] [Abstract][Full Text] [Related]
7. Does Extended PET Acquisition in PET/MRI Rectal Cancer Staging Improve Results?
Bailey JJ; Jordan EJ; Burke C; Ohliger MA; Wang ZJ; Van Loon K; Varma MG; Hope TA
AJR Am J Roentgenol; 2018 Oct; 211(4):896-900. PubMed ID: 30106609
[TBL] [Abstract][Full Text] [Related]
8. Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment.
Hunter CJ; Garant A; Vuong T; Artho G; Lisbona R; Tekkis P; Abulafi M; Brown G
Ann Surg Oncol; 2012 Apr; 19(4):1199-205. PubMed ID: 21913017
[TBL] [Abstract][Full Text] [Related]
9. Initial Staging of Locally Advanced Rectal Cancer and Regional Lymph Nodes: Comparison of Diffusion-Weighted MRI With 18F-FDG-PET/CT.
Cerny M; Dunet V; Prior JO; Hahnloser D; Wagner AD; Meuli RA; Schmidt S
Clin Nucl Med; 2016 Apr; 41(4):289-95. PubMed ID: 26828149
[TBL] [Abstract][Full Text] [Related]
10. Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer.
Gearhart SL; Frassica D; Rosen R; Choti M; Schulick R; Wahl R
Ann Surg Oncol; 2006 Mar; 13(3):397-404. PubMed ID: 16485158
[TBL] [Abstract][Full Text] [Related]
11. False-positive bone metastases on PET/CT secondary to sarcoidosis in a patient with rectal cancer.
Montini KM; Tulchinsky M
Clin Nucl Med; 2012 Mar; 37(3):307-10. PubMed ID: 22310266
[No Abstract] [Full Text] [Related]
12. FDG-PET/CT imaging for staging and target volume delineation in preoperative conformal radiotherapy of rectal cancer.
Bassi MC; Turri L; Sacchetti G; Loi G; Cannillo B; La Mattina P; Brambilla M; Inglese E; Krengli M
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1423-6. PubMed ID: 17931795
[TBL] [Abstract][Full Text] [Related]
13. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study.
Brændengen M; Hansson K; Radu C; Siegbahn A; Jacobsson H; Glimelius B
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e439-45. PubMed ID: 21641122
[TBL] [Abstract][Full Text] [Related]
14. [Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma].
Lin XP; Zhao C; Chen MY; Fan W; Zhang X; Zhi SF; Liang PY
Ai Zheng; 2008 Sep; 27(9):974-8. PubMed ID: 18799039
[TBL] [Abstract][Full Text] [Related]
15. Rectal cancer: a methodological approach to matching PET/MRI to histopathology.
Rutegård MK; Båtsman M; Blomqvist L; Rutegård M; Axelsson J; Ljuslinder I; Rutegård J; Palmqvist R; Brännström F; Brynolfsson P; Riklund K
Cancer Imaging; 2020 Oct; 20(1):80. PubMed ID: 33129352
[TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of 18-FDG-PET/MRI to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer. A prospective preliminary study.
Ferri V; Vicente Lopez E; Quijano Collazo Y; Caruso R; Duran Gimenez Rico H; Ielpo B; Diaz Reques E; Fabra Cabrera I; Malavè Cardozo L; Isernia R; Pinna E; Plaza Hernandezv C; Garcerant M; Garcia Cañamaques L; Perez Dueñas V
Acta Oncol; 2019 Sep; 58(9):1246-1249. PubMed ID: 31144557
[No Abstract] [Full Text] [Related]
18. Standardized Uptake Values from PET/MRI in Metastatic Breast Cancer: An Organ-based Comparison With PET/CT.
Pujara AC; Raad RA; Ponzo F; Wassong C; Babb JS; Moy L; Melsaether AN
Breast J; 2016 May; 22(3):264-73. PubMed ID: 26843433
[TBL] [Abstract][Full Text] [Related]
19. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of lymph node metastasis on rectal cancer by PET-CT computer imaging combined with MRI technology.
Li F; Hu J; Jiang H; Sun Y
J Infect Public Health; 2020 Sep; 13(9):1347-1353. PubMed ID: 31289005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
